Ōsaka, Japan Health News, Events and Opinion on Allvoices
Front Page

Ōsaka Health News

 
 
   
Source: National Public Radio

Fukushima :: Japan | updated 2012-05-09 07:20:52 -0700 | technology-news

March 9, 2012 One year ago this Sunday, a 9.0 magnitude earthquake off Japan triggered a tsunami that killed 20,000 people. It also triggered multiple meltdowns at the Fukushima Dai-ichi nuclear power station, one of the worst nuclear disasters in...
Credibility  
Views: 6   News Stories: 1
Blog Posts: 0 4 19 0
 
   
Posted by: Adrian Holman

Ōsaka :: Japan | updated 2012-07-28 03:12:11 -0700 | health-news

A recent study by a Japanese research group could pave the way for scientists to create new treatments that could help treat against degenerative diseases such as Alzheimer's and Parkinson's. The study was done at Osaka University, and it deals...
Credibility      Reach    
Views: 13   News Stories: 0
Blog Posts: 0 2 0 0
 
 
   
Source: Japan Times

Ōsaka :: Japan | updated 2012-01-22 21:40:35 -0800 | business-news

The plaintiffs appealed the ruling to the Supreme Court two days later. The high court appeared in a rush to make its ruling in the trial, which started in September. It held only two hearings and it took only three...
Credibility  
Views: 0   News Stories: 1
Blog Posts: 0 0 0 0
 
   
Source: Japan Today

Ōsaka :: Japan | updated 2011-02-18 02:08:19 -0800 | technology-news

A six-month-old girl born with a serious congenital rapid heartbeat has successfully had the abnormal portion of her heart muscle removed with a catheter in the first such surgery on an infant in Japan, an Osaka city hospital said Saturday....
Credibility  
Views: 12   News Stories: 1
Blog Posts: 0 0 0 0
 
Breaking News: Vegetarian diet linked to lower blood pressure
   
Posted by: Debbie Nicholson

Ōsaka :: Japan | updated 2014-02-27 00:52:01 -0800 | health-news

Vegetarian diet may be useful as a non-pharmacological approach to lower blood pressure Previous studies have suggested an association between vegetarian diets and lower blood pressure, but the relationship is not well-established. Researchers in Osaka, Japan, conducted a systematic review...
Credibility      Reach    
Views: 335   News Stories: 10
Blog Posts: 4 2 1 0
 
   
Source: Pharmaceutical Industry News

Ōsaka :: Japan | updated 2014-04-01 00:46:36 -0700 | health-news

L (Cell Cultured Influenza vaccine (Prototype)) for prevention of pandemic influenza. The new vaccine will be manufactured at a newly-established facility at the company's Hikari Plant in Hikari City, Yamaguchi Prefecture. In 2010, Takeda and Baxter International have entered into...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
 
   
Source: Pharmaceutical Industry News

Ōsaka :: Japan | updated 2014-03-02 22:08:54 -0800 | health-news

Discovered by Takeda, TAK-438 belongs to a new class of inhibitors called potassium-competitive acid blockers (P-CABs) that show strong and sustainable acid secretion inhibitory effects as well as demonstrate efficacy in early termination by inhibiting the binding of potassium ion...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Pharmaceutical Industry News

Ōsaka :: Japan | updated 2014-04-04 04:43:25 -0700 | health-news

Latuda, the antipsychotic agent, has been marketed for the treatment of schizophrenia in Canada by Sunovion Pharmaceuticals Canada, a subsidiary of the US-based Sunovion Pharmaceuticals. The company said that an application for the additional indications was submitted in August 2012...
Credibility  
Views: 3   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Pharmaceutical Industry News

Ōsaka :: Japan | updated 2014-03-28 10:23:22 -0700 | health-news

Discovered by Takeda, TAK-438 belongs to a new class of acid secretion inhibitors called potassium-competitive acid blockers (P-CAB). In February 2014, a new drug application (NDA) for TAK-438 was submitted in Japan by Takeda and is currently undergoing regulatory review....
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Pharmaceutical Industry News

Ōsaka :: Japan | updated 2014-03-26 08:10:29 -0700 | health-news

Earlier in March 2013, the company had submitted the marketing authorization application (MAA) to the TGA for review of Latuda. Lurasidone is an atypical antipsychotic agent, developed by DSP with an affinity for dopamine D2, serotonin 5-HT2A and serotonin 5-HT7...
Credibility  
Views: 2   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Japan Times

Ōsaka :: Japan | updated 2014-02-26 19:55:54 -0800 | health-news

Researchers have found that a drug used in the prevention of strokes, cilostazol, is effective in slowing the progression of mild dementia, according to a study published Thursday in the U.S. online science journal Plos One. The team including Masafumi...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
   
Source: Japan Times

Ōsaka :: Japan | updated 2014-04-07 08:27:45 -0700 | health-news

The researcher accused by the state-backed Riken institute of manipulating and fabricating parts of her purportedly trailblazing study on a new stem cell technique will hold a news conference Wednesday afternoon, her lawyer said Monday...Wednesday's news conference, scheduled to be...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Japan Times

Ōsaka :: Japan | updated 2014-03-19 02:42:50 -0700 | health-news

A U.S. scientist who assisted Haruko Obokata with what appeared to be groundbreaking stem cell research has corrected a paper she published in a U.S. magazine in 2011, citing an erroneous figure. Charles Vacanti, a professor at Harvard Medical School...
Credibility  
Views: 4   News Stories: 1
Blog Posts: 0 0 0 0
 
   
Source: Japan Times

Ōsaka :: Japan | updated 2014-04-23 05:54:45 -0700 | health-news

Cancer patients are 20 times more likely to commit suicide within the first year of their diagnosis than members of the general population, according to new findings. The study, released Tuesday by a research team at the National Cancer Center,...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 

Contributors

Build Your Allvoices Brand. Gain Influence. Make Money.

Join the Build Your Allvoices Brand Incentive Program



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.